The subthalamic nucleus (STN) and the globus pallidus internus (GPi) are the main targets for deep brain stimulation (DBS) in advanced Parkinson's disease (PD) [1]. So far, randomized trials have failed to demonstrate clear superiority of either target [2,3]. Long-term efficacy, however, appears to be better in STN DBS, with reports on a decline of stimulation efficacy in GPi patients [4][5][6][7][8]. Moreover, STN DBS has been successful to reverse GPi DBS failure [6][7][8].Herein we present the first case of a PD patient with secondary STN DBS failure successfully corrected by additional GPi DBS.Akinetic-rigid PD started at age of 30 years. Family history did not suggest a hereditary form of PD, and genetic diagnostics were refused by the patient. Levodopa therapy was effective but complicated by dyskinesias and fluctuations. At the age of 50 years, the patient presented irregular motor fluctuations and spent 25% of the day in an off state. During the on state she had violating and severely disabling dyskinesias. Unified Parkinson's Disease Rating Scale (UPDRS) motor scores in the off and on state at this time were 83 (including 6 tremor points) and 14 points (no tremor points), respectively (see video and Fig. 1). Daily levodopa equivalent dose (LEDD) was 550 mg, body weight was 58 kg, and height was 169 cm [body mass index (BMI) 20 kg/m 2 ]. After 1 year of STN DBS, UPDRS motor scores in the off and on state were 31 points and 19 points, respectively (see video and Fig. 1). LEDD was reduced to 350 mg and body weight increased to 72 kg (BMI 25 kg/m 2 ). Symptom control remained stable during the next year but declined thereafter. Technical dysfunction or dislocation of the stimulation electrodes was excluded by impedance measurements, control of stimulation effects/side-effects, and stereotactic computed tomography (CT) scan. After 4 years of STN DBS and recurrence of significant motor fluctuations and dyskinesias, continuous intestinal levodopa infusion therapy was initiated concomitant to STN DBS. However, this therapy only transiently improved fluctuations and dyskinesias. At the age of 58 years, after 8 years of STN DBS and 4 years of additional levodopa infusion therapy, UPDRS motor scores in the medication off and on state with continued STN DBS were 78 points (including 1 tremor point) and 35 points (including 1 tremor point), respectively (see video and Fig. 1). The patient had lost body weight down to 48 kg (BMI 17 kg/m 2 ). GPi DBS was considered, particularly because of the severe choreatiform dyskinesias in the on state. STN DBS in the medication off state still had a small but significant effect on akinesia and rigidity, so that we Electronic supplementary material The online version of this article (